Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06388642
PHASE1/PHASE2
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Sponsor: Clinuvel Europe Limited
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.
Official title: A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients With Erythropoietic Protoporphyria (EPP)
Key Details
Gender
All
Age Range
12 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2024-03-07
Completion Date
2025-01-20
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Afamelanotide 16mg implant
afamelanotide 16mg implant will be administered to each patient during the study.
Locations (2)
CLINUVEL Site
Leuven, Belgium
CLINUVEL Site
Rotterdam, Netherlands